Description
What it is / How it works
Dual GIP/GLP-1 receptor agonist that reduces appetite, slows gastric emptying and improves glucose regulation.
Common research interest
Obesity, weight management and type 2 diabetes.
Evidence / status
The active drug has FDA-approved prescription indications; research-vial products are distinct from FDA-approved branded medicines
